Well thanks for the information. Do you think i
Post# of 148187
Do you think i don't understand that the whole process is complicated, lined with legalities and requirements?
I may not know all the ends and outs of how the sausage is made. I do know that there is some sausage that looks, tastes and goes down a lot easier than others. Most PR's I read from other biotechs in this rapid fire covid drama are fairly easy to read and digest and understand. I literally get done reading one from CYDY and dont immediately know if it is good or bad news. They are so confusing at times.
If the hold up is our lawyer team, we need new or more lawyers (ugh i did i say more lawyers?) If the hold up is NP writing himself, he needs to know when to delegate or ask for help. Whatever it is it comes across as unprofessional. You can say i dont understand and should just suck it up and accept crappy correspondence, but we are not all perfect and need help from others to create a great team.
What i am saying is that the process of the exceptional results are based on procedural values of 10% being less worse in the second of two groups of 24 vs. the other non control group consisting of 13% of 32 where 15% of the placebo group faced a 42% more positive outcome in the 2:1 study conducted in 8 locations for 13 weeks starting 15 weeks ago, except for the one guy that died for some reason but not leronlimab. (if that makes any sense that is what i feel like when i read these PR's)
CytoDyn Inc (CYDY) Stock Research Links
Lamont
#1 30.58333 114.26667
#2 39.002744, -77.103470